Lv6
2926 积分 2022-05-02 加入
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
12小时前
待确认
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
12小时前
待确认
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
18小时前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
18小时前
已完结
Structural and anatomical changes in the retina due to sildenafil citrate overdose
1个月前
已关闭
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study
1个月前
已完结
Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal candidiasis: a randomised trial
1个月前
已完结
An open multicentre study of the efficacy and safety of a single dose of fluconazole 150 mg in the treatment of vaginal candidiasis in general practice
1个月前
已完结
Treatment of vaginal candidiasis with a single oral dose of fluconazole
1个月前
已完结
Vulvovaginal candidiasis-an overview of current trends and the latest treatment strategies
1个月前
已完结
皖公网安备34019202002308
